Pilot Study of [


Journal

Clinical genitourinary cancer
ISSN: 1938-0682
Titre abrégé: Clin Genitourin Cancer
Pays: United States
ID NLM: 101260955

Informations de publication

Date de publication:
10 2020
Historique:
received: 13 11 2019
revised: 03 02 2020
accepted: 03 02 2020
pubmed: 10 3 2020
medline: 19 8 2021
entrez: 10 3 2020
Statut: ppublish

Résumé

Computed tomography (CT) has limited diagnostic accuracy for staging of muscle-invasive bladder cancer (MIBC). [ Twenty-one patients with MIBC with planned radical cystectomy were enrolled. Two teams of radiologists reviewed FDG-PET/MRI scans to determine: (1) presence of primary bladder tumor; and (2) lymph node involvement and distant metastases. FDG-PET/MRI was compared with cystectomy pathology and computed tomography (CT). Eighteen patients were included in the final analysis, most (72.2%) of whom received neoadjuvant chemotherapy. Final pathology revealed 10 (56%) patients with muscle invasion and only 3 (17%) patients with lymph node involvement. Clustered analysis of FDG-PET/MRI radiology team reads revealed a sensitivity of 0.80 and a specificity of 0.56 for detection of the primary tumor with a sensitivity of 0 and a specificity of 1.00 for detection of lymph node involvement when compared with cystectomy pathology. CT imaging demonstrated similar rates in evaluation of the primary tumor (sensitivity, 0.91; specificity, 0.43) and lymph node involvement (sensitivity, 0; specificity, 0.93) when compared with pathology. This pilot single-institution experience of FDG-PET/MRI for preoperative staging of MIBC performed similar to CT for the detection of the primary tumor; however, the determination of lymph node status was limited by few patients with true pathologic lymph node involvement. Further studies are needed to evaluate the potential role for FDG-PET/MRI in the staging of MIBC.

Identifiants

pubmed: 32147364
pii: S1558-7673(20)30042-2
doi: 10.1016/j.clgc.2020.02.008
pii:
doi:

Substances chimiques

Radiopharmaceuticals 0
Fluorodeoxyglucose F18 0Z5B2CJX4D

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

378-386.e1

Subventions

Organisme : NCI NIH HHS
ID : P30 CA016086
Pays : United States

Informations de copyright

Copyright © 2020 Elsevier Inc. All rights reserved.

Auteurs

Patrick J Eulitt (PJ)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC.

Ersan Altun (E)

Division of Abdominal Imaging, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC.

Arif Sheikh (A)

Division of Nuclear Medicine, Department of Diagnostic, Molecular, and Interventional Radiology, Icahn School of Medicine at Mount Sinai, New York, NY.

Terence Z Wong (TZ)

Division of Nuclear Medicine, Department of Radiology, Duke University School of Medicine, Durham, NC.

Michael E Woods (ME)

Department of Urology, Loyola University Chicago Stritch School of Medicine, Chicago, IL.

Tracy L Rose (TL)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

Eric M Wallen (EM)

Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC.

Raj S Pruthi (RS)

Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC.

Angela B Smith (AB)

Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC.

Matthew E Nielsen (ME)

Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC.

Young E Whang (YE)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

William Y Kim (WY)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

Paul A Godley (PA)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

Ethan M Basch (EM)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

Grace U David (GU)

Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.

Juanita Ramirez (J)

Biomedical Research Imaging Center, University of North Carolina School of Medicine, Chapel Hill, NC.

Allison M Deal (AM)

Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC.

W Kimryn Rathmell (WK)

Division of Hematology/Oncology, Department of Medicine, Vanderbilt University School of Medicine, Nashville, TN.

Ronald C Chen (RC)

Department of Radiation Oncology, University of North Carolina School of Medicine, Chapel Hill, NC.

Marc A Bjurlin (MA)

Department of Urology, University of North Carolina School of Medicine, Chapel Hill, NC.

Weili Lin (W)

Biomedical Research Imaging Center, University of North Carolina School of Medicine, Chapel Hill, NC.

Joseph K Lee (JK)

Division of Abdominal Imaging, Department of Radiology, University of North Carolina School of Medicine, Chapel Hill, NC; Department of Diagnostic Imaging, National University Hospital of Singapore, Singapore.

Matthew I Milowsky (MI)

Division of Hematology/Oncology, Department of Medicine, University of North Carolina School of Medicine, Chapel Hill, NC; Lineberger Comprehensive Cancer Center, University of North Carolina, Chapel Hill, NC. Electronic address: matt_milowsky@med.unc.edu.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH